sellModerate cluster of 310b5-1 plan
BENKOWITZ MICHAEL sold $3.7M of UTHR
PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 10,000 shares at an average of $372.75, traded Nov 25, 2024, filed Nov 27, 2024.
Warning score
45Value
$3.7M
10,000 shares
Holdings after
0
-133% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-027799, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 25, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +7,500 | $102.11 | $766k | 7,500 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -398 | $368.76 | $147k | 7,102 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -500 | $369.46 | $185k | 6,602 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -300 | $371.15 | $111k | 6,302 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,455 | $372.20 | $542k | 4,847 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -3,208 | $373.17 | $1.2M | 1,639 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,116 | $374.15 | $418k | 523 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -423 | $375.07 | $159k | 100 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -100 | $376.18 | $38k | 0 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +2,500 | $111.00 | $278k | 2,500 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -284 | $368.84 | $105k | 2,216 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -532 | $372.09 | $198k | 1,684 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,082 | $373.39 | $404k | 602 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -402 | $374.35 | $150k | 200 | Nov 27, 2024 |
| Nov 25, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -200 | $375.12 | $75k | 0 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -7,500 | $0.00 | $0 | 12,000 | Nov 27, 2024 |
| Nov 25, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -2,500 | $0.00 | $0 | 37,000 | Nov 27, 2024 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 25Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $640k | 2,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.0M | 9,679 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.5M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.5M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 30Weak | sell10b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.